Bupa Arabia obtains SAMA Final Approval on insurance product for premium residency holders

Bupa Arabia for Cooperative Insurance Company announced on Tuesday that it has received the final approval from the Saudi Central Bank “SAMA” to sell its new insurance product “Bupa Premium Residency” in the Kingdom of Saudi Arabia under the registration number (P-BUPA-2-I-23-010).

The new product, “Bupa Premium Residency”, is a health insurance product. Bupa Premium Residency product provides premium health insurance coverage to the holders of premium residency and their dependents with access to Bupa Arabia’s best network of health insurance providers and table of benefits along with Bupa Arabia value-added services (Tebtom & Rahatkom) to accommodate for premium residents’ health requirements and needs. This product aims to grow Bupa Arabia’s individual business portfolio and enhances the premium residents’ experience in light of Vision 2030.

This new product is expected to have a positive impact on Bupa Arabia’s 2023 financial results.